- Home
- KROS vs SEAT Comparison
KROS vs SEAT Comparison
Compare KROS & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- SEAT
- Stock Information
- Founded
- KROS 2015
- SEAT 2001
- Country
- KROS United States
- SEAT United States
- Employees
- KROS N/A
- SEAT N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- SEAT Industrial Machinery/Components
- Sector
- KROS Health Care
- SEAT Industrials
- Exchange
- KROS Nasdaq
- SEAT Nasdaq
- Market Cap
- KROS 558.9M
- SEAT 366.2M
- IPO Year
- KROS 2020
- SEAT N/A
- Fundamental
- Price
- KROS $13.45
- SEAT $1.86
- Analyst Decision
- KROS Buy
- SEAT Buy
- Analyst Count
- KROS 13
- SEAT 11
- Target Price
- KROS $20.63
- SEAT $4.49
- AVG Volume (30 Days)
- KROS 603.2K
- SEAT 1.4M
- Earning Date
- KROS 08-06-2025
- SEAT 08-05-2025
- Dividend Yield
- KROS N/A
- SEAT N/A
- EPS Growth
- KROS N/A
- SEAT N/A
- EPS
- KROS 0.11
- SEAT N/A
- Revenue
- KROS $214,713,000.00
- SEAT $748,757,000.00
- Revenue This Year
- KROS $5,006.76
- SEAT N/A
- Revenue Next Year
- KROS N/A
- SEAT $4.42
- P/E Ratio
- KROS $123.44
- SEAT N/A
- Revenue Growth
- KROS 91657.70
- SEAT 0.82
- 52 Week Low
- KROS $9.12
- SEAT $1.44
- 52 Week High
- KROS $72.37
- SEAT $5.74
- Technical
- Relative Strength Index (RSI)
- KROS 43.42
- SEAT 51.89
- Support Level
- KROS $13.24
- SEAT $1.60
- Resistance Level
- KROS $13.77
- SEAT $1.94
- Average True Range (ATR)
- KROS 0.38
- SEAT 0.13
- MACD
- KROS -0.04
- SEAT 0.03
- Stochastic Oscillator
- KROS 28.00
- SEAT 70.27
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.